Our products

  • Myvelpa

    MyVelpa

    Sofosbuvir/Velpatasvir tablet is indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults

  • Hepcinat LP

    Hepcinat LP

    Hepcinat LP is a fixed-dose combination tablet containing Ledipasvir 90mg and Sofosbuvir 400 mg for oral administration used with or without ribavirin for the treatment of chronic (lasting a long time) hepatitis C virus (HCV) genotype 1, 4, 5 or 6 infection.

  • ledvir

    Ledvir

    Ledvir is a direct acting anti-viral agent used to treat chronic hepatitis C (HCV) genotype 1 infection in adults.